A health worker administers a COVID-19 vaccine at a government school, in New Delhi, India, Thursday, Jan. 20, 2022. (AP Photo/Manish Swarup) (AP)
2 min read . 05:19 PM IST - Pharma firms SII and Bharat Biotech had submitted applications to the DCGI seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin, which are currently only authorised for emergency use in the country
